In Vitro Fertilization Outcomes in Metabolic Syndrome

May 10, 2016 updated by: Meir Medical Center

The Influence of Metabolic Syndrome on in Vitro Fertilization Treatment Outcome

The purpose of this study is to examine the effect of metabolic syndrome in over-weight women on IVF treatment outcomes.

Study Overview

Status

Completed

Conditions

Detailed Description

This porpuse of the study is to examine the physiology of CRP during the IVF cycle in and to evaluated the effect of CRP in patient with and without metabolic syndrome on IVF outcomes

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Israel
      • Kfar-Saba, Israel
        • Sapir Medical Center, Meir Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

women undergoing ivf treatment in "Meir" medical center in "Kfar-Saba, Israel

Description

Inclusion Criteria:

  • women undergoing ivf treatment

Exclusion Criteria:

  • inflammatory disease
  • acute conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
women with metabolic syndrome
women undergoing ivf treatment who have BMI>25 and meet the criteria for metabolic syndrome
women without metabolic syndrome
women undergoing ivf treatment who have BMI>25 and who do not meet the criteria for metabolic syndrome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
success or failure of ivf treatment
Time Frame: within 1 year from intiation of ivf treatment
success or failure of a treatment will be determined by beta-Human chorionic gonadotropin test, number of oocyte retrieved or fertilized and embryos quality.
within 1 year from intiation of ivf treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
blood levels of C-reactive protein
Time Frame: within 1 year from initiation of ivf treatment
within 1 year from initiation of ivf treatment
follicle liquid levels of C-reactive protein
Time Frame: within 1 year from initiation of ivf treatment
within 1 year from initiation of ivf treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Meir Medical Center

Investigators

  • Principal Investigator: Amir Waiser, M.D, "Meir", Medical centere

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

October 6, 2013

First Submitted That Met QC Criteria

October 8, 2013

First Posted (Estimate)

October 9, 2013

Study Record Updates

Last Update Posted (Estimate)

May 11, 2016

Last Update Submitted That Met QC Criteria

May 10, 2016

Last Verified

October 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MMC-16092013-CTIL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe